title: Short tandem repeat polymorphism in exon 4 of esophageal cancer related gene 2 predicts relapse of oral squamous cell carcinoma.
abstract: Short tandem repeat (STR) polymorphisms in exon 4 of esophageal cancer related gene 2 (ECRG2) are a prognostic marker for squamous cell carcinoma (SCC) of the esophagus. The aim of the present study was to correlate these STRs with clinical outcome of the similar tumor type oral squamous cell carcinoma (OSCC). DNA of 81 patients that underwent complete surgical resection of OSCC was analyzed for STRs TCA3/TCA3, TCA3/TCA4 and TCA4/TCA4 in exon 4 of ECRG2 by PCR, capillary electrophoresis and DNA sequencing. ECRG2 STR TCA3/TCA3 were found in 45 (56%), TCA3/TCA4 in 33 (41%) and TCA4/TCA4 in 3 (3%) patients. TCA3/TCA3 was significantly associated with reduced relapse-free survival of OSCC, compared with TCA3/TCA4 and TCA4/TCA4 genotypes (P<0.05; log-rank test). TCA3/TCA3 STR was independent prognostic factor determined by multivariate Cox regression analysis (p<0.05). STR polymorphism TCA3/TCA3 in exon 4 of ECRG2 is associated with poor relapse-free survival in surgically completely resected OSCC patients and might be a potential prognostic marker.
authors.affiliation: Department of Oral Surgery, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany. blessman@uke.uni-hamburg.de <blessman@uke.uni-hamburg.de>
authors.forename: Marco
authors.initials: M
authors.lastname: Blessmann
authors.forename: Jussuf T
authors.initials: JT
authors.lastname: Kaifi
authors.forename: Paulus G
authors.initials: PG
authors.lastname: Schurr
authors.forename: Asli
authors.initials: A
authors.lastname: Cihan
authors.forename: Viacheslav
authors.initials: V
authors.lastname: Kalinin
authors.forename: Florian
authors.initials: F
authors.lastname: Trump
authors.forename: Artun
authors.initials: A
authors.lastname: Atac
authors.forename: Max
authors.initials: M
authors.lastname: Heiland
authors.forename: Philipp
authors.initials: P
authors.lastname: Pohlenz
authors.forename: Felix
authors.initials: F
authors.lastname: Blake
authors.forename: Rainer
authors.initials: R
authors.lastname: Schmelzle
authors.forename: Jakob R
authors.initials: JR
authors.lastname: Izbicki
mesh_terms: D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000473:pathology; D005091:Exons; D005260:Female; D005819:Genetic Markers; D006801:Humans; D008297:Male; D018895:Microsatellite Repeats / Q000235:genetics*; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000235:genetics* / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000235:genetics* / Q000473:pathology; D011110:Polymorphism, Genetic; D011379:Prognosis; D053491:Proteinase Inhibitory Proteins, Secretory; D012189:Retrospective Studies; D000074162:Serine Peptidase Inhibitors, Kazal Type; D016019:Survival Analysis; D025521:Tumor Suppressor Proteins
chemical_list: D005819:Genetic Markers; D053491:Proteinase Inhibitory Proteins, Secretory; C473799:SPINK7 protein, human; D000074162:Serine Peptidase Inhibitors, Kazal Type; D025521:Tumor Suppressor Proteins